Publikationen in Zusammenarbeit mit Forschern von Duke University (2)

2020

  1. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

    Journal of Hepatology, Vol. 72, Núm. 5, pp. 885-895

2019

  1. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    The Lancet, Vol. 394, Núm. 10215, pp. 2184-2196